Literature DB >> 16179898

Cancer and venous thromboembolism: scope of the problem.

John A Heit1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16179898     DOI： 10.1177/1073274805012003S02

Source DB:  PubMed          Journal:  Cancer Control        ISSN： 1073-2748            Impact factor:   3.302


× No keyword cloud information.
  25 in total

Review 1.  Risk factors for venous and arterial thrombosis.

Authors:  Emanuele Previtali; Paolo Bucciarelli; Serena M Passamonti; Ida Martinelli
Journal:  Blood Transfus       Date:  2010-10-25       Impact factor: 3.443

Review 2.  Tissue factor and tissue factor pathway inhibitor as key regulators of global hemostasis: measurement of their levels in coagulation assays.

Authors:  Raj S Kasthuri; Sam L Glover; Jeremiah Boles; Nigel Mackman
Journal:  Semin Thromb Hemost       Date:  2010-10-26       Impact factor: 4.180

3.  Prognostic and predictive value of plasma D-dimer levels in patients with small-cell lung cancer.

Authors:  Cuicui Zhang; Yongsheng Jia; Yanan Jia; Xiaoling Zhang; Kai Li
Journal:  Int J Clin Oncol       Date:  2018-08-27       Impact factor: 3.402

4.  Adherence to treatment guidelines for cancer-associated thrombosis: a French hospital-based cohort study.

Authors:  I Mahé; H Puget; J C Buzzi; M Lamuraglia; J Chidiac; A Strukov; Hélène Helfer; A Perozziello
Journal:  Support Care Cancer       Date:  2016-03-16       Impact factor: 3.603

Review 5.  Risk of venous and arterial thromboembolic events in cancer patients treated with gemcitabine: a systematic review and meta-analysis.

Authors:  Wei-Xiang Qi; Feng Lin; Yuan-Jue Sun; Li-Na Tang; Zan Shen; Yang Yao
Journal:  Br J Clin Pharmacol       Date:  2013-09       Impact factor: 4.335

6.  Impact of venous thromboembolism on mortality of elderly Medicare patients with stage III colon cancer.

Authors:  Nader Hanna; Kaloyan A Bikov; Diane McNally; Nneka C Onwudiwe; Mehul Dalal; C Daniel Mullins
Journal:  Oncologist       Date:  2012-07-05

Review 7.  Long-term use of daily subcutaneous low molecular weight heparin in cancer patients with venous thromboembolism: why hesitate any longer?

Authors:  Philippe Debourdeau; Ismail Elalamy; Axelle de Raignac; Paul Meria; Jean Marc Gornet; Yahovi Amah; Wolfang Korte; Michel Marty; Dominique Farge
Journal:  Support Care Cancer       Date:  2008-08-15       Impact factor: 3.603

8.  Thromboembolic Events Associated with Bevacizumab plus Chemotherapy for Patients with Colorectal Cancer: A Meta-Analysis of Randomized Controlled Trials.

Authors:  Abdullah K Alahmari; Ziyad S Almalki; Ahmed K Alahmari; Jeff J Guo
Journal:  Am Health Drug Benefits       Date:  2016-06

Review 9.  Role of tissue factor in cancer.

Authors:  Raj S Kasthuri; Mark B Taubman; Nigel Mackman
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544

10.  Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study.

Authors:  Siân Sweetland; Jane Green; Bette Liu; Amy Berrington de González; Marianne Canonico; Gillian Reeves; Valerie Beral
Journal:  BMJ       Date:  2009-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.